Home›Companies›Biotech & Pharma›LumaCyte

LumaCyte, Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 14, 2023·Suggest an edit

About LumaCyte

LumaCyte is a private company based in Charlottesville, Virginia. It has reported $21,053,056 raised in eight offerings on Form D since May 2014. Its chief executive is Sean Hart.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 21, 2023Sep 14, 2023$9,999,994of $12.9M target1$9.9MEquity, Equity to be issued upon conversion of previously issued convertible securitiesRule 506(b)Form D ↗
Jan 4, 2021May 17, 2022$550,000fully sold3$183KSecurities offered are convertible notes.Rule 506(b)Form D ↗
May 7, 2019May 17, 2022$1,170,000fully sold6$195KSecurities offered are convertible notes.Rule 506(b)Form D ↗
May 22, 2019May 17, 2022$1,250,000fully sold2$625KSecurities offered are convertible notes.Rule 506(b)Form D ↗
Jul 15, 2018May 17, 2022$750,000fully sold1$750KSecurities offered are convertible notes.Rule 506(b)Form D ↗
Apr 16, 2017May 17, 2022$525,000fully sold2$262KSecurities offered are convertible notes.Rule 506(b)Form D ↗
Feb 15, 2022Mar 2, 2022$6,777,982of $9.3M target3$2.2MEquityRule 506(b)Form D ↗
Apr 30, 2014May 12, 2014$30,080of $2.0M target1$30,080EquityRule 506(b)Form D ↗
Total, eight offerings$21,053,056

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on LumaCyte's Form D filed Sep 14, 2023.

PM
Paul Meister
Director
SH
Sean Hart
Chief Executive Officer and director
RH
RH
Renee Hart
Executive officer and director

Earlier filings also listed Pete Buzy (director, last listed Mar 2022).

Sources

  1. SECLumaCyte, Inc. filing history